Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten J Cramer

Showing results (61-70 of 216) with videos related to

Pageof 22
Sort By:
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|May 18, 2022
Histopathological evaluation of chronic rheumatic mitral valve stenosis: the association with clinical presentation, pathogenesis, and management at a National Cardiac Institute, TanzaniaReuben K Mutagaywa, Amos Mwakigonja, Pilly Chillo, et al.
American Journal of Physiology. Renal Physiology|August 24, 2012
Target organ cross talk in cardiorenal syndrome: animal modelsLennart G Bongartz, Branko Braam, Carlo A Gaillard, et al.
International Journal of Cardiology|March 22, 2015
Prognosis of screen-detected heart failure with reduced and preserved ejection fraction in patients with type 2 diabetesLeandra J M Boonman-de Winter, Arno W Hoes, Maarten J Cramer, et al.
Journal of Hypertension|October 26, 2019
Dissociation between hypertrophy and fibrosis in the left ventricle early after experimental kidney transplantationMerle M Krebber, Diana A Papazova, Nynke R Oosterhuis, et al.
Diabetes Care|June 4, 2015
Effect of Type 2 Diabetes on Recurrent Major Cardiovascular Events for Patients With Symptomatic Vascular Disease at Different LocationsManon C Stam-Slob, Yolanda van der Graaf, Gert Jan de Borst, et al.
JACC. Cardiovascular Imaging|February 14, 2021
Right Ventricular Functional Abnormalities in Arrhythmogenic Cardiomyopathy: Association With Life-Threatening Ventricular ArrhythmiasFeddo P Kirkels, Øyvind H Lie, Maarten J Cramer, et al.
Diabetes Care|August 27, 2015
Body weight, metabolic dysfunction, and risk of type 2 diabetes in patients at high risk for cardiovascular events or with manifest cardiovascular disease: a cohort studyBas T Franssens, Yolanda van der Graaf, L Jaap Kappelle, et al.
BMC Medicine|December 27, 2022
Diastolic dysfunction and sex-specific progression to HFpEF: current gaps in knowledge and future directionsA M L N van Ommen, E Dal Canto, Maarten J Cramer, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 6, 2010
[Hypertrophic cardiomyopathy: DNA diagnosis, genetic counselling and the risk of sudden cardiac death]Hubert F Baars, Imke Christiaans, Pim T A M de Nijs, et al.
Diabetes, Obesity & Metabolism|May 8, 2019
Mediation analysis of the relationship between type 2 diabetes and cardiovascular events and all-cause mortality: Findings from the SMART cohortShahnam Sharif, Rolf H H Groenwold, Yolanda van der Graaf, et al.
Pageof 22

Showing results (61-70 of 216) with videos related to

Sort By:
Pageof 22
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|May 18, 2022
Histopathological evaluation of chronic rheumatic mitral valve stenosis: the association with clinical presentation, pathogenesis, and management at a National Cardiac Institute, TanzaniaReuben K Mutagaywa, Amos Mwakigonja, Pilly Chillo, et al.
American Journal of Physiology. Renal Physiology|August 24, 2012
Target organ cross talk in cardiorenal syndrome: animal modelsLennart G Bongartz, Branko Braam, Carlo A Gaillard, et al.
International Journal of Cardiology|March 22, 2015
Prognosis of screen-detected heart failure with reduced and preserved ejection fraction in patients with type 2 diabetesLeandra J M Boonman-de Winter, Arno W Hoes, Maarten J Cramer, et al.
Journal of Hypertension|October 26, 2019
Dissociation between hypertrophy and fibrosis in the left ventricle early after experimental kidney transplantationMerle M Krebber, Diana A Papazova, Nynke R Oosterhuis, et al.
Diabetes Care|June 4, 2015
Effect of Type 2 Diabetes on Recurrent Major Cardiovascular Events for Patients With Symptomatic Vascular Disease at Different LocationsManon C Stam-Slob, Yolanda van der Graaf, Gert Jan de Borst, et al.
JACC. Cardiovascular Imaging|February 14, 2021
Right Ventricular Functional Abnormalities in Arrhythmogenic Cardiomyopathy: Association With Life-Threatening Ventricular ArrhythmiasFeddo P Kirkels, Øyvind H Lie, Maarten J Cramer, et al.
Diabetes Care|August 27, 2015
Body weight, metabolic dysfunction, and risk of type 2 diabetes in patients at high risk for cardiovascular events or with manifest cardiovascular disease: a cohort studyBas T Franssens, Yolanda van der Graaf, L Jaap Kappelle, et al.
BMC Medicine|December 27, 2022
Diastolic dysfunction and sex-specific progression to HFpEF: current gaps in knowledge and future directionsA M L N van Ommen, E Dal Canto, Maarten J Cramer, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 6, 2010
[Hypertrophic cardiomyopathy: DNA diagnosis, genetic counselling and the risk of sudden cardiac death]Hubert F Baars, Imke Christiaans, Pim T A M de Nijs, et al.
Diabetes, Obesity & Metabolism|May 8, 2019
Mediation analysis of the relationship between type 2 diabetes and cardiovascular events and all-cause mortality: Findings from the SMART cohortShahnam Sharif, Rolf H H Groenwold, Yolanda van der Graaf, et al.
Pageof 22